Bone disorders in cholestatic liver diseases

Area of Science:

• Hepatology
• Endocrinology
• Bone Metabolism

Background:

• Osteopenia is a frequent complication of cholestatic liver diseases (CLD), impacting 10-56% of patients.
• Primary biliary cirrhosis (PBC) is most commonly associated with osteopenia, but other CLDs like PSC and alcoholic liver disease also contribute.
• The exact mechanisms causing bone disease in chronic cholestasis remain unclear, with ongoing debate about osteomalacia versus osteoporosis.

Purpose of the Study:

• To review the prevalence, diagnostic methods, pathophysiology, and treatment strategies for osteopenia in patients with cholestatic liver diseases.
• To consolidate current understanding of bone disease in chronic cholestasis.
• To highlight the clinical significance of osteopenia in CLD, particularly concerning fracture risk.

Main Methods:

• Literature review of studies on osteopenia in cholestatic liver diseases.
• Analysis of prevalence data across different CLDs.
• Discussion of diagnostic tools including bone mineral density measurements and laboratory tests.
• Synthesis of current knowledge on the pathogenesis and treatment of bone disease in CLD.

Main Results:

• Osteopenia is a significant complication of CLD, with varying prevalence depending on the specific liver condition.
• Bone mineral density measurement is crucial for assessing osteopenia severity in CLD.
• Laboratory tests provide insights into the metabolic bone status.
• Osteopenia increases the risk of atraumatic fractures, especially in PBC patients post-liver transplantation on corticosteroids.

Conclusions:

• Osteopenia is a prevalent and serious complication of cholestatic liver diseases requiring careful management.
• Accurate diagnosis through bone density assessment and laboratory tests is essential.
• Further research is needed to fully elucidate the pathogenesis and optimize treatment strategies for bone disease in CLD.